ArticleRheumatology international2010
Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China.
Article in Rheumatology international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 31 citations in OpenAlex.
- Potential role of HBV DNA-induced CD8The Journal of international medical research · 2022Article
- High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus.International journal of molecular sciences · 2021Article
- Article
- Prevalence of hepatitis B virus and hepatitis C virus infection in patients with systemic lupus erythematosus: a systematic review and meta-analysis.Oncotarget · 2017Article
- HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA.Iranian journal of public health · 2017Article
- Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.The Korean journal of internal medicine · 2017Review
- Hepatitis B carrier state among SLE patients: case-control study.Immunologic research · 2017Article
- Hepatitis B Virus Infection Rate and Distribution in Chinese Systemic Lupus Erythematosus Patients.Medical science monitor : international medical journal of experimental and clinical research · 2015Article
- Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.Frontiers in immunology · 2015Review
- Prevalence of hepatitis B surface antigen in patients with ankylosing spondylitis and its association with HLA-B27: a retrospective study from south China.Rheumatology international · 2012Article
- A potential explanation of the reported low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus.Rheumatology international · 2012Article
- Clinical significance of chronic hepatitis B virus infection in patients with primary Sjögren's syndrome.Clinical rheumatology · 2012Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate the prevalence of hepatitis B virus (HBV) infection in systemic lupus erythematosus (SLE) patients in southern China, SLE inpatients were retrospectively investigated for their HBV infection rate. Fifteen SLE patients positive for hepatitis B surface antigen (HBsAg) were followed up. Furthermore, serum interferon (IFN)-α levels among SLE patients were detected by ELISA. Results showed estimated HBsAg-positive rate was 10.74% in general population. The HBsAg-positive rate was lower in SLE patients compared with controls (2.33 vs. 9.57%, P < 0.01). Interestingly, 13 out of 15 SLE patients converted from HBsAg positive to HBV surface antibody (HBsAb) positive even under glucocorticoid therapy. In addition, we found significantly increased IFN-α levels in SLE patients.The prevalence of HBV infection in SLE patients was lower than that in sex- and age-matched non-SLE controls in southern China. The characteristic IFN signatures in SLE may favor the subsequent clearance of HBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.